A new study published by the Journal of Headache and Pain has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis – may treat migraines.
The study, titled Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model, used male rats to study the effects of a cannabinoid receptor agonist (an activator) on the treatment of severe migraines.
“[The agonist] showed a significant analgesic effect in baseline conditions in both tests”, states the study. “Furthermore, when administered 3 hours after NTG [nitroglycerin, a pain reliver] administration, [the agonist] at both doses significantly reduced the total number of flinches/shakes during phase II of the test.”
The study can be found by clicking here.